Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. Transmedics Group Inc
TMDX

Buy TMDX Stock

TMDX
See TMDX stock price and Buy/Sell Transmedics Group Inc with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
TMDX

Transmedics Group Inc (TMDX)

About Transmedics Group Inc (TMDX)

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is he...Read more
Market Cap
$1.48B
1 Year High
$49.27
Volume
225.76k
1 Year Low
$10
Price to Earnings Ratio
Open
$47.18
Dividend Rate
High
$48.49
Dividend Yield
Low
$46.44

Community

People who own or watch TMDX stock

TMDX Stock News

TMDX stock rating

What analysts recommend for TMDX stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell
1.4

TMDX price target

What analysts think TMDX will be worth
Low $10
High $49.27
Current $47
Target $47.60

Events

List of events that could affect TMDX stock.
01Aug

Earnings data Q2 2022

08Nov

Earnings data Q3 2022

TMDX earnings

The value each share was expected to gain vs. the value that each share actually gained
0
-0.16
-0.31
-0.47
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022

Expected EPS
Q3 2022
-$0.42
Actual EPS
Q3 2022

Buy TMDX Stock

TMDX
See TMDX stock price and Buy/Sell Transmedics Group Inc with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch TMDX stock
  • joseberrios avatar
  • lim avatar
  • rm1024 avatar
  • sidneyxfox avatar
  • tothetop avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.